PET detection of the impact of dobutamine on myocardial glucose metabolism in women with type 1 diabetes mellitus

Journal of Nuclear Cardiology

Volumn 15, Issue 6, 2008, Pages 791-799

  Herrero, Pilar ^a   McGill, Janet ^b   Lesniak, Donna S ^a   Dence, Carmen S ^a   Scott, Shalonda W ^a   Kisrieva Ware, Zulfia ^a   Gropler, Robert J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

catecholamines; Diabetes mellitus; metabolism; tomography

Indexed keywords

DOBUTAMINE; FATTY ACID; GLUCOSE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; FATTY ACID METABOLISM; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART MUSCLE PERFUSION; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; OXYGEN CONSUMPTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REST;

ADULT; CATECHOLAMINES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DOBUTAMINE; FEMALE; GLUCOSE; HUMANS; INSULIN; MIDDLE AGED; MYOCARDIUM; OXYGEN; OXYGEN CONSUMPTION; PHENOTYPE; POSITRON-EMISSION TOMOGRAPHY;

EID: 54449089716     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03007360     Document Type: Article

References (32)

1. Avogaro A., Nosadini R., Doria A., Fioretto P., Velussi M., Vigorito C., et al. Myocardial metabolism in insulin-deficient diabetic humans without coronary artery disease. Am J Physiol 258 (1990) E606-E618
2. Doria A., Nosadini R., Avogaro A., Fioretto P., and Crepaldi G. Myocardial metabolism in type 1 diabetic patients without coronary artery disease. Diabet Med (1991) S104-S107 8 Spec No
3. Herrero P., Peterson L.R., McGill J.B., Matthew S., Lesniak D., Dence C., et al. Increased myocardial fatty acid metabolism in patients with type 1 diabetes mellitus. J Am Coll Cardiol 47 (2006) 598-604
4. Randle P.J., Garland P.B., Hales C.N., and Newsholme E.A. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 13 (1963) 785-789
5. Rodrigues B., Cam M.C., and McNeill J.H. Myocardial substrate metabolism: implications for diabetic cardiomyopathy. J Mol Cell Cardiol 27 (1995) 169-179
6. Severson D.L. Diabetic cardiomyopathy: Recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol 82 (2004) 813-823
7. Duncan J.G., Fong J.L., Medeiros D.M., Finck B.N., and Kelly D.P. Insulin-resistant heart exhibits a mitochondrial biogenic response driven by the peroxisome proliferator-activated receptor-alpha/PGC-1alpha gene regulatory pathway. Circulation 115 (2007) 909-917
8. Finck B.N., Han X., Courtois M., Aimond F., Nerbonne J.M., Kovacs A., et al. A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: Modulation by dietary fat content. Proc Natl Acad Sci U S A 100 (2003) 1226-1231
9. Finck B.N., Lehman J.J., Leone T.C., Welch M.J., Bennett M.J., Kovacs A., et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 109 (2002) 121-130
10. Monti L.D., Lucignani G., Landoni C., Moresco R.M., Piatti P., Stefani I., et al. Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients. Role of free fatty acid and insulin levels. Diabetes 44 (1995) 537-542
11. Voipio-Pulkki L.M., Nuutila P., Knuuti M.J., Ruotsalainen U., Haaparanta M., Teras M., et al. Heart and skeletal muscle glucose disposal in type 2 diabetic patients as determined by positron emission tomography. J Nucl Med 34 (1993) 2064-2067
12. Peterson L.R., Soto P.F., Herrero P., Schechtman K.B., Dence C., and Gropler R.J. Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol 14 (2007) 573-581
13. de las Fuentes L., Herrero P., Peterson L.R., Kelly D.P., Gropler R.J., and Davila-Roman V.G. Myocardial fatty acid metabolism: independent predictor of left ventricular mass in hypertensive heart disease. Hypertension 41 (2003) 83-87
14. Peterson L.R., Herrero P., Schechtman K.B., Racette S.B., Waggoner A.D., Kisrieva-Ware Z., et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 109 (2004) 2191-2196
15. Takala T.O., Nuutila P., Knuuti J., Luotolahti M., and Yki-Jarvinen H. Insulin action on heart and skeletal muscle glucose uptake in weight lifters and endurance athletes. Am J Physiol 276 (1999) E706-E711
16. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
17. Young M.E. The circadian clock within the heart: Potential influence on myocardial gene expression, metabolism, and function. Am J Physiol Heart Circ Physiol 290 (2006) H1-H162
18. Bergmann S.R., Herrero P., Markham J., Weinheimer C.J., and Walsh M.N. Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol 14 (1989) 639-652
19. Bergmann S.R., Weinheimer C.J., Markham J., and Herrero P. Quantitation of myocardial fatty acid metabolism using positron emission tomography. J Nucl Med 37 (1996) 1723-1730
20. Buck A., Wolpers H.G., Hutchins G.D., Savas V., Mangner T.J., Nguyen N., et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med 32 (1991) 1950-1957
21. 11C-glucose and kinetic modeling. J Nucl Med 48 (2007) 955-964
22. Herrero P., Weinheimer C.J., Dence C., Oellerich W.F., and Gropler R.J. Quantification of myocardial glucose utilization by PET and 1-carbon-11-glucose. J Nucl Cardiol 9 (2002) 5-14
23. Hall J.L., Stanley W.C., Lopaschuk G.D., Wisneski J.A., Pizzurro R.D., Hamilton C.D., et al. Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work. Am J Physiol 271 (1996) H2320-H2329
24. Vadlamudi R.V., Rodgers R.L., and McNeill J.H. The effect of chronic alloxan- and streptozotocin-induced diabetes on isolated rat heart performance. Can J Physiol Pharmacol 60 (1982) 902-911
25. Chatham J.C., Gao Z.P., and Forder J.R. Impact of 1 wk of diabetes on the regulation of myocardial carbohydrate and fatty acid oxidation. Am J Physiol 277 (1999) E342-E351
26. Chatham J.C., Gao Z.P., Bonen A., and Forder J.R. Preferential inhibition of lactate oxidation relative to glucose oxidation in the rat heart following diabetes. Cardiovasc Res 43 (1999) 96-106
27. Ungar I., Gilebrt M., Siegel M.S., Blain J.M., and Bing R.J. Studies on myocardial metabolism. IV. Myocardial metabolism in diabetes. Am J Med 18 (1955) 385-396
28. Desrois M., Sidell R.J., Gauguier D., King L.M., Radda G.K., and Clarke K. Initial steps of insulin signaling and glucose transport are defective in the type 2 diabetic rat heart. Cardiovasc Res 61 (2004) 288-296
29. Huisamen B., van Zyl M., Keyser A., and Lochner A. The effects of insulin and beta-adrenergic stimulation on glucose transport, glut 4 and PKB activation in the myocardium of lean and obese non-insulin dependent diabetes mellitus rats. Mol Cell Biochem 223 (2001) 15-25
30. Lipworth B.J. Clinical pharmacology of beta 3-adrenoceptors. Br J Clin Pharmacol 42 (1996) 291-300
31. Goodwin G.W., Ahmad F., Doenst T., and Taegtmeyer H. Energy provision from glycogen, glucose, and fatty acids on adrenergic stimulation of isolated working rat hearts. Am J Physiol 274 (1998) H1239-H1247
32. Soto P.F., Herrero P., Kates A.M., Dence C.S., Ehsani A.A., Davila-Roman V., et al. Impact of aging on myocardial metabolic response to dobutamine. Am J Physiol Heart Circ Physiol 285 (2003) H2158-H2164